Publications - John M. Miles, M.D.

Back to research profile

  1. Sathananthan M, Farrugia LP, Miles JM, Piccinini F, Man CD, Zinsmeister AR, Cobelli C, Rizza RA, Vella A. Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, beta-Cell Function and Glucose Metabolism in Non-Diabetic Subjects. Diabetes. 2013 Apr 01. [Epub ahead of print]
    View PubMed
  2. Curry TB, Somaraju M, Hines CN, Groenewald CB, Miles JM, Joyner MJ, Charkoudian N. Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. Obesity (Silver Spring). 2013 Mar; 21(3):480-5.
    View PubMed
  3. Nelson RH, Mundi MS, Vlazny DT, Smailovic A, Muthusamy K, Almandoz JP, Singh E, Jensen MD, Miles JM. Kinetics of saturated, monounsaturated, and polyunsaturated fatty acids in humans. Diabetes. 2013 Mar; 62(3):783-8. Epub 2012 Dec 28.
    View PubMed
  4. Almandoz JP, Singh E, Howell LA, Grothe K, Vlazny DT, Smailovic A, Irving BA, Nelson RH, Miles JM. Spillover of Fatty Acids during Dietary Fat Storage in Type 2 Diabetes: Relationship to Body Fat Depots and Effects of Weight Loss. Diabetes. 2013 Jan 24. [Epub ahead of print]
    View PubMed
  5. McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013 Jan; 37(1):23-36. Epub 2012 Jun 29.
    View PubMed
  6. Veldhuis JD, Norman C, Miles JM, Bowers CY. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men. J Clin Endocrinol Metab. 2012 Dec; 97(12):4753-60. Epub 2012 Sep 18.
    View PubMed
  7. Nelson RH, Vlazny D, Smailovic A, Miles JM. Intravenous niacin acutely improves the efficiency of dietary fat storage in lean and obese humans. Diabetes. 2012 Dec; 61(12):3172-5. Epub 2012 Aug 24.
    View PubMed
  8. Muthusamy K, Nelson RH, Singh E, Vlazny D, Smailovic A, Miles JM. Effect of insulin infusion on spillover of meal-derived fatty acids. J Clin Endocrinol Metab. 2012 Nov; 97(11):4201-5. Epub 2012 Sep 13.
    View PubMed
  9. Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, Gura K, Miles JM, Valentine CJ, Kochevar M, Novel Nutrient Task Force Intravenous Fat Emulsions Workgroup, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012 Apr; 27(2):150-92. Epub 2012 Feb 29.
    View PubMed
  10. Veldhuis JD, Iranmanesh A, Roelfsema F, Aoun P, Takahashi P, Miles JM, Keenan DM. Tripartite control of dynamic ACTH-cortisol dose responsiveness by age, body mass index, and gender in 111 healthy adults. J Clin Endocrinol Metab. 2011 Sep; 96(9):2874-81. Epub 2011 Jul 13.
    View PubMed
  11. Veldhuis JD, Erickson D, Wigham J, Weist S, Miles JM, Bowers CY. Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men. J Clin Endocrinol Metab. 2011 Aug; 96(8):2540-7. Epub 2011 May 25.
    View PubMed
  12. Veldhuis JD, Erickson D, Miles JM, Bowers CY. Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp. Am J Physiol Endocrinol Metab. 2011 Jun; 300(6):E1158-65. Epub 2011 Apr 05.
    View PubMed
  13. Curry TB, Roberts SK, Basu R, Basu A, Schroeder D, Joyner MJ, Miles JM. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab. 2011 Apr; 300(4):E746-51. Epub 2011 Feb 08.
    View PubMed
  14. Goel K, Thomas RJ, Squires RW, Coutinho T, Trejo-Gutierrez JF, Somers VK, Miles JM, Lopez-Jimenez F. Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease. Am Heart J. 2011 Mar; 161(3):590-7.
    View PubMed
  15. Hudson SB, Schroeder DR, Bailey JN, Mielke KL, Erickson D, Miles JM, Bowers CY, Veldhuis JD. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. J Clin Endocrinol Metab. 2010 Jan; 95(1):353-60. Epub 2009 Oct 26.
    View PubMed
  16. Sparks LM, Pasarica M, Sereda O, deJonge L, Thomas S, Loggins H, Xie H, Miles JM, Smith SR. Effect of adipose tissue on the sexual dimorphism in metabolic flexibility. Metabolism. 2009 Nov; 58(11):1564-71.
    View PubMed
  17. Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism. Eur J Endocrinol. 2009 Aug; 161(2):293-300. Epub 2009 May 20.
    View PubMed
  18. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009 Jul; 32(7):1335-43.
    View PubMed
  19. Veldhuis JD, Keenan DM, Bailey JN, Adeniji AM, Miles JM, Bowers CY. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp. J Clin Endocrinol Metab. 2009 Jun; 94(6):2137-43. Epub 2009 Apr 07.
    View PubMed
  20. Veldhuis JD, Mielke KL, Cosma M, Soares-Welch C, Paulo R, Miles JM, Bowers CY. Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. J Clin Endocrinol Metab. 2009 Mar; 94(3):973-81. Epub 2008 Dec 16.
    View PubMed
  21. Veldhuis JD, Keenan DM, Bailey JN, Adeniji A, Miles JM, Paulo R, Cosma M, Soares-Welch C. Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion. J Clin Endocrinol Metab. 2009 Jan; 94(1):246-54. Epub 2008 Nov 04.
    View PubMed
  22. Rooyackers O, Mori M, Miles J. Report of the 9th SIG Tracer Methodology meeting in Florence, 2008. e-SPEN. 2009; 4(4):e206-7.
  23. Veldhuis JD, Keenan DM, Bailey JN, Adeniji A, Miles JM, Paulo R, Cosma M, Soares-Welch C. Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I. J Clin Endocrinol Metab. 2008 Nov; 93(11):4471-8. Epub 2008 Aug 26.
    View PubMed
  24. Kok P, Paulo RC, Cosma M, Mielke KL, Miles JM, Bowers CY, Veldhuis JD. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women. J Clin Endocrinol Metab. 2008 Oct; 93(10):4020-6. Epub 2008 Jul 08.
    View PubMed
  25. Miles JM, McMahon MM, Isley WL. No, the glycaemic target in the critically ill should not be < or = 6.1 mmol/l. Diabetologia. 2008 Jun; 51(6):916-20. Epub 2007 Dec 20.
    View PubMed
  26. Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr; 31(4):643-7. Epub 2008 Jan 09.
    View PubMed
  27. Cosma M, Bailey J, Miles JM, Bowers CY, Veldhuis JD. Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women. J Clin Endocrinol Metab. 2008 Mar; 93(3):951-8. Epub 2007 Dec 18.
    View PubMed
  28. Paulo RC, Cosma M, Soares-Welch C, Bailey JN, Mielke KL, Miles JM, Bowers CY, Veldhuis JD. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men. J Clin Endocrinol Metab. 2008 Mar; 93(3):944-50. Epub 2007 Dec 11.
    View PubMed
  29. Miles JM, McMahon MM, Isley WL. For Debate: No, the glycaemic target in the critically ill should not be ≤ 6.1 mmol/1 Diabetologia. 2008; 51:916-20.
  30. Nelson RH, Basu R, Johnson CM, Rizza RA, Miles JM. Splanchnic spillover of extracellular lipase-generated fatty acids in overweight and obese humans. Diabetes. 2007 Dec; 56(12):2878-84. Epub 2007 Sep 19.
    View PubMed
  31. Miles JM, Nelson RH. Contribution of triglyceride-rich lipoproteins to plasma free fatty acids. Horm Metab Res. 2007 Oct; 39(10):726-9.
    View PubMed
  32. Nelson RH, Edgerton DS, Basu R, Roesner JC, Cherrington AD, Miles JM. Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs. Diabetes. 2007 Jul; 56(7):1850-5. Epub 2007 Apr 06.
    View PubMed
  33. Isley WL, Miles JM, Harris WS. Pilot study of combined therapy with omega-3 fatty acids and niacin in atherogenic dyslipidemia. J Clin Lipidol. 2007 Jul; 1(3):211-7. Epub 2007 May 18.
    View PubMed
  34. Nelson RH, Prasad A, Lerman A, Miles JM. Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes. 2007 Feb; 56(2):527-30.
    View PubMed
  35. Isley WL, Miles JM, Harris WS. Combined therapy with n-3 fatty acids and niacin in atherogenic dyslipidemia. J Clin Lipidol. 2007; 1:211-17.
  36. Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women. J Clin Endocrinol Metab. 2006 Sep; 91(9):3559-65. Epub 2006 Jun 27.
    View PubMed
  37. Isley WL, Harris WS, Miles JM. The effect of high-dose simvastatin on free fatty acid metabolism in patients with type 2 diabetes mellitus. Metabolism. 2006 Jun; 55(6):758-62.
    View PubMed
  38. Miles JM. Energy expenditure in hospitalized patients: implications for nutritional support. Mayo Clin Proc. 2006 Jun; 81(6):809-16.
    View PubMed
  39. Veldhuis JD, Iranmanesh A, Mielke K, Miles JM, Carpenter PC, Bowers CY. Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone. J Clin Endocrinol Metab. 2006 Jun; 91(6):2441-6. Epub 2006 Mar 14.
    View PubMed
  40. McMahon MM, Miles JM. Glycemic control and nutrition in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2006 Mar; 9(2):120-3.
    View PubMed
  41. Isley WL, Miles JM, Patterson BW, Harris WS. The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus. J Lipid Res. 2006 Jan; 47(1):193-200. Epub 2005 Oct 28.
    View PubMed
  42. Nelson RH, Miles JM. Use of orlistat in obese, dyslipidemic patients. Future Lipidology. 2006; 1:267-75.
  43. Veldhuis JD, Erickson D, Iranmanesh A, Miles JM, Bowers CY. Sex-steroid control of the aging somatotropic axis. Endocrinology & Metabolism Clinics of North America. 2005 Dec; 34(4):877-93.
  44. Nelson RH, Miles JM. The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes. Expert Opin Pharmacother. 2005 Nov; 6(14):2483-91.
    View PubMed
  45. Veldhuis JD, Keenan DM, Mielke K, Miles JM, Bowers CY. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy. European Journal of Endocrinology. 2005 Oct; 153(4):577-86.
    View PubMed
  46. Coppack SW, Chinkes DL, Miles JM, Patterson BW, Klein S. A multicompartmental model of in vivo adipose tissue glycerol kinetics and capillary permeability in lean and obese humans. Diabetes. 2005 Jul; 54(7):1934-41.
    View PubMed
  47. Soares-Welch C, Farhy L, Mielke KL, Mahmud FH, Miles JM, Bowers CY, Veldhuis JD. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults. J Clin Endocrinol Metab. 2005 Apr; 90(4):2225-32. Epub 2005 Jan 05.
    View PubMed
  48. Miles JM, Jensen MD. The role of visceral fat in the pathogenesis of insulin resistance: marker or mediator? Diabetes Care. 2005; 28:2326-28.
  49. Erickson D, Keenan DM, Mielke K, Bradford K, Bowers CY, Miles JM, Veldhuis JD. Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp. J Clin Endocrinol Metab. 2004 Sep; 89(9):4746-54.
    View PubMed
  50. Choong NWW, Miles JM. Bilateral carotid body paraganglioma. Mayo Clin Proc. 2004 May; 79(5):681.
    View PubMed
  51. Miles JM, Park YS, Walewicz D, Russell-Lopez C, Windsor S, Isley WL, Coppack SW, Harris WS. Systemic and forearm triglyceride metabolism - Fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes. 2004 Mar; 53(3):521-7.
    View PubMed
  52. Miles JM. Insulin in the early management of diabetic complications. J Assoc Physicians India. 2003 May; 51:501-5.
    View PubMed
  53. Miles JM, Wooldridge D, Grellner WJ, Windsor S, Isley WL, Klein S, Harris WS. Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects-effects of insulin sensitization therapy. Diabetes. 2003 Mar; 52(3):675-81.
    View PubMed
  54. Martindale R, Miles J. Is immunonutrition ready for prime time? Two points of view. Nutr Clin Prac. 2003; 18:489-496.
  55. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S. What does the measurement of whole body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes. 2003; 52:1641-1648.
    View PubMed
  56. Patel JN, Coppack SW, Goldstein DS, Miles JM, Eisenhofer G. Norepinephrine spillover from human adipose tissue before and after a 72-hour fast. J Clin Endocrinol Metab. 2002 Jul; 87(7):3373-7.
    View PubMed
  57. Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care. 2002 Jul; 25(7):1123-8.
    View PubMed
  58. Kelley DE, Pi-Sunyer FX, Hollander P, Klein S, Miles J, Wing R, Bray GA. A One-Year, Randomized, Double-Blind Study of Orlistat in Obese Insulin-Treated Patients with Type 2 Diabetes Mellitus. Diabetes Care. 2002; 25:1033-41.
    View PubMed
  59. Park Y, Damron BD, Miles JM, Harris WS. Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. Lipids. 2001 Feb; 36(2):115-20.
    View PubMed
  60. Miles JM, Park Y, Harris WS. Lipoprotein lipase and triglyceride-rich lipoprotein metabolism. Nutr Clin Prac. 2001; 16:273-9.
  61. Park Y, Grellner WJ, Harris WS, Miles JM. A new method for the study of chylomicron kinetics in vivo. Am J Physiol. 2000; 279:E1258-63.
  62. Patel J, Coppack SW, Rawesh A, Miles JM, Eisenhofer G. Regional and total body changes in sympathoadrenal activity in response to eating. Int J Obesity. 2000; 2(24 Suppl):S156-7.
  63. O'Keefe Jr JH, Miles JM, Harris WH, Moe RM, McCallister BD. Improving the adverse cardiovascular prognosis of Type 2 Diabetes. Mayo Clin Proc. 1999; 74:171-80.
    View PubMed
  64. Coppack SW, Persson M, Judd R, Miles JM. Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol. 1999; 39:E233-40.
  65. Goldstein DS, Swoboda KJ, Miles JM, Coppack SW, Aneman A, Holmes C, Lamensdorf I, Eisenhofer G. Sources and physiological significance of plasma dopamine sulfate. J Clin Endo Metab. 1999; 84:2523-31.
  66. Patel JN, Eisenhofer G, Coppack SW, Miles JM. Norepinephrine spillover in forearm and subcutaneous adipose tissue before and after eating. J Clin Endo Metab. 1999; 84:2815-9.
  67. Judd RL, Nelson R, Klein S, Jensen MD, Miles JM. Measurement of plasma glycerol specific activity by high performance liquid chromatography to determine glycerol flux. J Lipid Res. 1998 May; 39(5):1106-10.
    View PubMed
  68. Divertie GD, Jensen MD, Cryer PE, Miles JM. Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans. Am J Physiol. 1997 Jun; 272(6 Pt 1):E1130-5.
    View PubMed
  69. Fisher RM, Miles JM, Kottke BA, Frayn KN, Coppack SW. Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue. Metabolism: Clinical & Experimental. 1997 Jun; 46(6):605-10.
    View PubMed
  70. Zhang T, Murray M, Klocke K, Miles JM, Holman RT. Effects of the incubation of long-chain polyunsaturated fatty acids on platelet lipids and thromboxane release. Prostaglandins Leukotrienes & Essential Fatty Acids. 1997 Apr; 56(4):259-64.
    View PubMed
  71. Mohamed-Ali V, Goodrick S, Rawesh A, Miles JM, Katz D, Yudkin JS, Coppack SW. Subcutaneous adipose tissue secretes interleukin-6 but not tumour necrosis factor-alpha in vitro. J Clin Endo Metab. 1997; 82:4196-200.
  72. Coppack SW, Persson M, Miles JM. Phenylalanine kinetics in human adipose tissue. J Clin Invest. 1996 Aug 1; 98(3):692-7.
    View PubMed
  73. Cersosimo E, Danou F, Persson M, Miles JM. Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. Am J Physiol. 1996 Jul; 271(1 Pt 1):E123-6.
    View PubMed
  74. Miles JM. Should protein be included or excluded from calorie counts? Nutr Clin Prac. 1996; 11:204-6.
  75. Klein S, Miles J. Substrate metabolism in humans. JPEN. 1996; 20:13-9.
  76. Coppack SW, Yost TJ, Fisher RM, Eckel RH, Miles JM. Periprandial systemic and regional lipase activity in normal man. Am J Physiol. 1996; 270:E718-22.
    View PubMed
  77. Dinneen S, Alzaid A, Miles J, Rizza R. Effects of the normal nocturnal rise in cortisol on carbohydrate and fat metabolism in IDDM. Am J Physiol. 1995 Apr; 268(4 Pt 1):E595-603.
    View PubMed
  78. O'Keefe JH, Nguyen T, Nelson J, O'Keefe L, Miles J. Potential beneficial effects of monounsaturated and polyunsaturated fats in elderly patients with or at risk of coronary artery disease. Cardiology in the Elderly. 1995 Feb; 3:5-10.
  79. Kinsey GC, Murray MJ, Swensen SJ, Miles JM. Glucose content of tracheal aspirates: implications for the detection of tube feeding aspiration. Crit Care Med. 1994 Oct; 22(10):1557-62.
    View PubMed
  80. Cersosimo E, Judd RL, Miles JM. Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest. 1994 Jun; 93(6):2584-9.
    View PubMed
  81. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res. 1994 Feb; 35(2):177-93.
    View PubMed
  82. Lynch JW, Miles JM, Bailey JW. Effects of the short-chain triglyceride, triacetin on intestinal mucosa and metabolic substrates in rats. JPEN. 1994; 18:208-13.
  83. Miles JM. Energy requirements in nutrition support: quantitative and qualitative considerations. Frontiers Clin Nutr. 1994; 3:9-12.
  84. Miles JM. Techniques for the measurement of ketone body and lactate kinetics in vivo. Diabetes Reviews. 1994; 2:239-48.
  85. Klein S, Miles JM. Metabolic Effects of Long-Chain and Medium-Chain Triglyceride Emulsions in Humans. JPEN. 1994; 18:396-7.
  86. Bleiberg B, Beers TR, Persson M, Miles JM. Metabolism of triacetin-derived acetate in dogs. Am J Clin Nutr. 1993 Dec; 58:908-911.
    View PubMed
  87. Bailey JW, Miles JM, Haymond MW. Effect of parenteral administration of short-chain triglycerides on leucine metabolism. Am J Clin Nutr. 1993 Dec; 58(6):912-6.
    View PubMed
  88. Dinneen S, Alzaid A, Miles J, Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest. 1993 Nov; 92(5):2283-90.
    View PubMed
  89. Hamel N, Divertie G, Silverberg J, Persson M, Miles J. Tracer disequilibrium in CO2 compartments during NaH14CO3 infusion. Metabolism: Clinical & Experimental. 1993 Aug; 42(8):993-7.
    View PubMed
  90. Fisher RM, Coppack SW, Kottke BA, Miles JM. Very low density lipoprotein subfraction apolipoprotein composition. Biochem Soc Trans. 1993 Aug; 21 ( Pt 3)(3):231S.
    View PubMed
  91. McMahon M, Miles JM. Common errors in enteral and parenteral nutrition support. Seminars in Gastrointestinal Disease. 1993; 4:127-36.
  92. Miles JM. Lipid fuel metabolism in health and disease. Curr Opin Gen Surg. 1993; 1:78-84.
  93. Elahi D, McAloon-Dyke M, Fukagawa N, Sclater A, Wong G, Shannon RP, Minaker K, Miles J, Rubenstein A, Vandepol C, Guler H-P, Good W, Seaman J, Wolfe R. The effects of human recombinant IGF-I on glucose and leucine kinetics in man. Am J Physiol. 1993; 256:E831-838.
  94. Miles JM. Pearls of diabetic management. The Practice of Internal Medicine-1992 1992 May 11-15; 97-100.
  95. Bleiberg B, Beers TR, Persson M, Miles JM. Systemic and regional acetate kinetics in the dog. Am J Physiol. 1992; 262:E197-202.
    View PubMed
  96. Heiling VJ, Miles JM, Jensen MD. How valid are isotopic measurements of fatty acid oxidation? Am J Physiol. 1991 Nov; 261(PART 1 OF 2 PARTS):E572-E577.
    View PubMed
  97. Persson M, Bleiberg B, Kiss D, Miles J. Measurement of plasma acetate kinetics using high-performance liquid chromatography. Anal Biochem. 1991 Oct; 198(1):149-53.
    View PubMed
  98. Bailey JW, Jensen MD, Miles JM. Effects of intravenous methyl palmoxirate on the turnover and oxidation of fatty acids in conscious dogs. Metabolism. 1991 Apr; 40(4):428-31.
    View PubMed
  99. Jensen MD, Heiling VJ, Miles JM. Effects of glucagon on free fatty acid metabolism in humans. J Clin Endocrinol Metab. 1991 Feb; 72(2):308-15.
    View PubMed
  100. Miles JM, Cattalini M, Sharbrough FW, Wold LE, Wharen RE Jr, Gerich JE, Haymond MW. Metabolic and neurologic effects of an intravenous medium-chain triglyceride emulsion. JPEN J Parenter Enteral Nutr. 1991 Jan-Feb; 15(1):37-41.
    View PubMed
  101. Bailey JW, Haymond MW, Miles JM. Triacetin: a potential parenteral nutrient. JPEN J Parenter Enteral Nutr. 1991 Jan-Feb; 15(1):32-6.
    View PubMed
  102. Miles JM. Intravenous fat emulsions in nutritional support. Curr Opin Gastroenterol. 1991; 7(2):306-11.
  103. Keller U, Miles JM. Growth hormone and lipids. Horm Res 36 ( 1991; Suppl. 1):36-40.
  104. Divertie GD, Jensen MD, Miles J. Stimulation of lipolysis in humans by physiological hypercortisolemia. Diabetes. 1991; 40:1228-1232.
    View PubMed
  105. Caruso M, Divertie GD, Jensen MD, Miles JM. Lack of effect of hyperglycemia on lipolysis in humans. Am J Physiol. 1990 Oct; 259(4 Pt 1):E542-7.
    View PubMed
  106. Bailey JW, Haymond MW, Miles JM. Metabolism of ketone bodies by skeletal muscle in starvation and uncontrolled diabetes. Metabolism. 1990 Oct; 39:1039-1043.
    View PubMed
  107. Bailey JW, Haymond MW, Miles JM. Validation of two-pool model for in vivo ketone body kinetics. Am J Physiol. 1990 May; 258(5 Pt 1):E850-5.
    View PubMed
  108. Ruegemer JJ, Squires RW, Marsh HM, Haymond MW, Cryer PE, Rizza RA, Miles JM. Differences between prebreakfast and late afternoon glycemic responses to exercise in IDDM patients. Diabetes Care. 1990 Feb; 13(2):104-10.
    View PubMed
  109. Jensen MD, Heiling V, Miles JM. Measurement of non-steady-state free fatty acid turnover. Am J Physiol. 1990 Jan; 258(1 Pt 1):E103-8.
    View PubMed
  110. Haymond MW, Tessari P, Beaufrere B, Rodriguez N, Bailey J, Miles JM. Fatty acid chain length affects leucine metabolism during parenteral infusions of triglycerides. Int Congr Ser. 1990; 872:333-338.
  111. Horber FF, Krayer S, Miles J, Cryer P, Rehder K, Haymond MW. Isoflurane and whole body leucine, glucose and fatty acid metabolism in dogs. Anesthesiology. 1990; 73:82-92.
    View PubMed
  112. Jensen MD, Caruso M, Heiling V, Miles JM. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes. 1989 Dec; 38(12):1595-601.
    View PubMed
  113. Rodriguez NR, Miles JM, Schwenk WF, Haymond MW. Effects of acute metabolic acidosis and alkalosis on leucine metabolism in conscious dogs. Diabetes. 1989 Jul; 38(7):847-53.
    View PubMed
  114. Bowyer BA, Fleming CR, Haymond MW, Miles JM. L-carnitine: effect of intravenous administration on fuel homeostases in normal subjects and home-parenteral-nutrition patients with low plasma carnitine concentrations. Am J Clin Nutr. 1989 Apr; 49:618-623.
    View PubMed
  115. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989 Apr; 83(4):1168-73.
    View PubMed
  116. Bailey JW, Heath H 3rd, Miles JM. Calcium, magnesium, and phosphorus metabolism in dogs given intravenous triacetin. Am J Clin Nutr. 1989 Feb; 49(2):385-8.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.